← Open Payments lookup

ELIZABETH MUSCATIELLO: Open Payments

NPI 1841672136 · BURLINGTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$650 in 31 payments from 14 companies in 2025. Trend: 2023 $477 · 2024 $580 · 2025 $650

Food & beverage: $650
CompanyPaymentsAmount
ABBVIE INC.11$161
Takeda Pharmaceuticals U.S.A., Inc.3$104
PFIZER INC.3$69
Gilead Sciences, Inc.3$67
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$47
Alnylam Pharmaceuticals Inc.1$31
GENZYME CORPORATION1$30
IRONWOOD PHARMACEUTICALS, INC1$29
Regeneron Healthcare Solutions, Inc.1$25
Lilly USA, LLC1$23

Products named: ENTYVIO, RINVOQ, LINZESS, DUPIXENT, XIFAXAN, XELJANZ, GIVLAARI, CREON.

Industry payments across MA — which companies pay providers there.